{
    "eid": "2-s2.0-85166759387",
    "title": "Effects of Metformin on Prevention and Treatment of Biliary Tract Cancer: A Meta-analysis of Observational Studies",
    "cover-date": "2023-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Biology",
            "@code": "1312",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Genetics",
            "@code": "1311",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Cholangiocarcinoma",
        "Diabetes mellitus",
        "Metformin",
        "Risk factor",
        "Survival"
    ],
    "authors": [
        "Suangson Supabphol",
        "Luxzup Wattanasukchai",
        "Seksan Nasomjit",
        "Wunchana Seubwai",
        "Sopit Wongkham",
        "Charupong Saengboonmee"
    ],
    "citedby-count": 0,
    "ref-count": 42,
    "ref-list": [
        "Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinoma",
        "Association of diabetes mellitus and cholangiocarcinoma: Update of evidence and the effects of antidiabetic medication",
        "Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis",
        "Are common factors involved in the pathogenesis of primary liver cancers?. A meta-analysis of risk factors for intrahepatic cholangiocarcinoma",
        "High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation",
        "Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma",
        "The IGF2/IR/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinoma",
        "Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study",
        "Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk",
        "Incretin-based therapy and risk of cholangiocarcinoma: a nested casecontrol study in a population of subjects with type 2 diabetes",
        "An updated review on cancer risk associated with incretin mimetics and enhancers",
        "Effect of the GLP-1 analog exendin-4 and oxaliplatin on intrahepatic cholangiocarcinoma cell line and mouse model",
        "Metformin and biliary tract cancer in patients with type 2 diabetes",
        "Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020",
        "Metformin-mode of action and clinical implications for diabetes and cancer",
        "Metformin exerts antiproliferative and antimetastatic effects against cholangiocarcinoma cells by targeting STAT3 and NF-\u03baB",
        "Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma",
        "Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours",
        "No decreased risk of gastrointestinal cancers in users of metformin in the netherlands; a time-varying analysis of metformin exposure",
        "Phase II study of the combination of abemaciclib and pembrolizumab in locally advanced unresectable or metastatic gastroesophageal adenocarcinoma: Big ten cancer research consortium BTCRC-GI18-149",
        "Decreased risk of cholangiocarcinoma in diabetic patients treated with metformin",
        "Aspirin, statins, non-aspirin NSAIDs, metformin, and the risk of biliary cancer: A Swedish population-based cohort study",
        "Metformin use and survival in patients with advanced extrahepatic cholangiocarcinoma: A single-center cohort study in Fuyang, China",
        "Metformin use and the risk of cancer in patients with diabetes: A nationwide sample cohort study",
        "Metformin does not improve survival of cholangiocarcinoma patients with diabetes",
        "Effects of statin, aspirin or metformin use on recurrence-free and overall survival in patients with biliary tract cancer",
        "Effects of metformin and vitamin d on clinical outcome in cholangiocarcinoma patients",
        "Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: a systematic review and meta-analysis",
        "Effects of metformin on risk and prognosis of biliary tract cancer: A systematic review and meta-analysis",
        "Metformin exerts anti-cancerogenic effects and reverses epithelialto-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells",
        "Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway",
        "Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo",
        "Obesity and cholangiocarcinoma: A review of epidemiological and molecular associations",
        "Risk Factors for cholangiocarcinoma in Thailand: A systematic review and meta-analysis",
        "Biliary cancer: intrahepatic cholangiocarcinoma vs. extrahepatic cholangiocarcinoma vs. gallbladder cancers: classification and therapeutic implications",
        "Risk factors for gallbladder cancer and cholangiocarcinoma: Similarities, differences and updates",
        "Cholangiocarcinoma 2020: the next horizon in mechanisms and management",
        "Repurposing metformin for cancer treatment: A great challenge of a promising drug",
        "A phase Ib clinical trial of metformin and chloroquine in patients with IDH1-mutated solid tumors",
        "Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes",
        "Metformin and pancreatic cancer risk in patients with type 2 diabetes",
        "Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus"
    ],
    "affiliation": [
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60026046",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60017165",
            "affilname": "Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017165",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kalasin",
            "@id": "130043855",
            "affilname": "Nonsung Health Promotion Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/130043855",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Research Council of Thailand",
        "Thailand Science Research and Innovation"
    ]
}